Our Mission Statement

NRG Oncology seeks to improve the lives of patients with cancer by conducting practice-changing multi-institutional clinical and translational research with emphases on gender-associated malignancies including gynecologic, breast, and prostate cancers and on localized or locally advanced cancers of all types.

Our Scientific Focus

Scientific Plan and Structure Established for NRG Oncology

With the submission of the NRG Oncology grant proposal to the National Cancer Institute (NCI) on January 15, the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG) took the formal step toward becoming the cancer clinical cooperative group NRG Oncology. These three groups have more than 150 years' cumulative experience in conducting practice-defining, multiinstitutional phase II and III trials sponsored primarily by the NCI, as well as a history of undertaking the kind of phase I trials and translational biological studies that will be imperative for future clinical cancer research.

Read more on the Scientific Focus page

Our Organizational Structure

Overview of Committees

The Concept Prioritization Advisory Committee, Research Strategy Committee, various scientific committees, and administrative committees, as shown in the figure below, will carry out research planning and the implementation of NRG Oncology functions.

Read more on the Organizational Structure page

Our Legacy Groups

NRG Oncology Foundation

The NRG Oncology Foundation Board is chaired by one of NRG Oncology’s group chairs and consists of 17 members: the three group chairs, six appointments by the chairs, three representatives from the institutions, the contact principal investigator for the NRG Oncology Statistical and Data Management Center, a patient advocate, an outside financial expert, a National Cancer Institute (NCI) Community Oncology Research Program (NCORP) representative, and an ad hoc member appointed by the group chairs.

The board ensures the appropriate allocation of NRG Oncology resources, allowing the group to fulfill its mission of improving the lives of adults with localized or locally advanced malignancies through the conduct of multi-institutional research trials. All other committees will be responsible for submitting or presenting their reports and recommendations to the board for review.